Company intelligence / Profile preview

Early Access Care

Ownership: Private
Development stage: Commercial

Overview

Early Access Care is a specialist service provider that designs and manages Compassionate Use and Named Patient Programs. The company offers end-to-end operational management, regulatory support, real-world data services, protocol development, and customized solutions to help biotech and pharmaceutical companies provide early or expanded access to investigational medicines before or after approval. They handle all regulatory and logistical aspects of early access globally.

Industry: Contract Research Organization

Partnerships

Works with multiple biotech and pharma clients as partners in setting up early/expanded access programs

Beyond the preview

Go deeper on Early Access Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Early Access Care.

Explore the full profile